BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 18242020)

  • 1. Characterisation of solid dispersions of paracetamol and EUDRAGIT E prepared by hot-melt extrusion using thermal, microthermal and spectroscopic analysis.
    Qi S; Gryczke A; Belton P; Craig DQ
    Int J Pharm; 2008 Apr; 354(1-2):158-67. PubMed ID: 18242020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
    Zajc N; Obreza A; Bele M; Srcic S
    Int J Pharm; 2005 Mar; 291(1-2):51-8. PubMed ID: 15707731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
    DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman spectroscopy for the in-line polymer-drug quantification and solid state characterization during a pharmaceutical hot-melt extrusion process.
    Saerens L; Dierickx L; Lenain B; Vervaet C; Remon JP; De Beer T
    Eur J Pharm Biopharm; 2011 Jan; 77(1):158-63. PubMed ID: 20933084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
    Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
    J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of polymer carriers with regard to the bioavailability enhancement of bifendate solid dispersions prepared by hot-melt extrusion.
    Feng J; Xu L; Gao R; Luo Y; Tang X
    Drug Dev Ind Pharm; 2012 Jun; 38(6):735-43. PubMed ID: 21999610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the influence of drug-polymer interactions on the miscibility, processability and structure of polyvinylpyrrolidone-based hot melt extrusion formulations.
    Chan SY; Qi S; Craig DQ
    Int J Pharm; 2015 Dec; 496(1):95-106. PubMed ID: 26428633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization of hot melt extruded bicalutamide-polyvinylpyrrolidone solid dispersions.
    Andrews GP; AbuDiak OA; Jones DS
    J Pharm Sci; 2010 Mar; 99(3):1322-35. PubMed ID: 19798757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
    Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
    Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential scanning calorimetry and surface morphology studies on coated pellets using aqueous dispersions.
    Nisar-ur-Rahman ; K H Y; Jia Woei W; Khan NA
    Pak J Pharm Sci; 2005 Apr; 18(2):19-23. PubMed ID: 16431393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of drug release from polymethacrylate-based extrudates and milled strands prepared by hot-melt extrusion.
    Albers J; Alles R; Matthée K; Knop K; Nahrup JS; Kleinebudde P
    Eur J Pharm Biopharm; 2009 Feb; 71(2):387-94. PubMed ID: 18951978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
    Ozgüney I; Shuwisitkul D; Bodmeier R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of plasticiser type on the hot melt extrusion of venlafaxine hydrochloride.
    Bounartzi M; Panagopoulou A; Kantiranis N; Malamataris S; Nikolakakis I
    J Pharm Pharmacol; 2014 Feb; 66(2):297-308. PubMed ID: 24433428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.